Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. It develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Disease.

Pharmaceutical

Ipsen

Ipsen's headquarters in Boulogne-Billancourt, France

David Loew

Laura Réveillon

Régis Mulot

Roberta Pozzo

Olivia Brown

Katherine Lai

Gonzalo Colimodio

Philippe Lopes-Fernandes

Jennifer Benenson

Christelle Huguet

Josep Catllà

Keira Driansky

Sandra Silvestri

Mari Scheiffele

Aymeric le Chatelier

Henri Beaufour

Marc De Garidel

Antoine Flochel

Margaret Liu

Piet Wigerinck

Naomi Binoche

Anne Beaufour

Philippe Bonhomme

Laetitia Ducroquet

Michèle Ollier

Karen Witts

Carol Xueref

Pascal Touchon

The Leadership Team at Ipsen is responsible for driving the strategic direction and operational effectiveness of the company. This diverse group of executives collaborates to make critical decisions across key areas such as research and development, regulatory affairs, commercial operations, mergers and acquisitions, and corporate governance. By leveraging their combined expertise in specialty pharmaceuticals, the team ensures that Ipsen remains at the forefront of innovation while advancing its mission in Oncology, Neuroscience, and Rare Diseases.

Leadership Team

The Clinical Affairs Team at Ipsen is dedicated to advancing the development of innovative therapies within Oncology, Neuroscience, and Rare Diseases. This team is responsible for designing and managing clinical trials, ensuring compliance with regulatory standards, and analyzing data to support the efficacy and safety of new treatments. Their collaborative efforts focus on bridging clinical science and operational execution to drive successful outcomes in patient care and product development.

Clinical Affairs Team

The Data and Technology Team at Ipsen plays a pivotal role in harnessing data-driven insights to support innovative biopharmaceutical development and enhance operational efficiencies. This team focuses on developing and executing data strategies, ensuring quality and compliance across IT systems, and facilitating the integration of advanced technologies to optimize research and commercialization processes in Oncology, Neuroscience, and Rare Diseases. Collaborating closely with other departments, they strive to leverage data science and technology to drive strategic transformation and improve patient outcomes.

Data and Technology Team

The Research and Development Team at Ipsen is dedicated to advancing innovative biopharmaceuticals in Oncology, Neuroscience, and Rare Disease. Composed of experts in drug development, clinical science, and external innovation, the team collaborates to design, conduct, and analyze research that drives the creation of impactful therapies, ensuring they meet regulatory standards and address unmet medical needs.

Research and Development Team

The Procurement and Supply Chain Team at Ipsen is responsible for strategically sourcing materials and services essential for the development and commercialization of innovative biopharmaceuticals. This team ensures efficient supply chain operations, manages vendor relationships, and oversees procurement processes across global markets, all while adhering to high standards of business ethics and compliance. Their efforts support Ipsen's mission to deliver transformative therapies in Oncology, Neuroscience, and Rare Diseases.

Procurement and Supply Chain Team

The Sales and Marketing Team at Ipsen plays a crucial role in driving the commercial success of innovative biopharmaceuticals across Oncology, Neuroscience, and Rare Diseases. This team focuses on market access, pricing strategies, and effective promotion of specialty medications, ensuring they reach the right patients while maximizing market penetration. Through collaboration and strategic planning, they enhance product visibility and foster relationships with healthcare professionals to advocate for Ipsen's innovative therapies.

Sales and Marketing Team

Ipsen

Org chart

Board & advisors

Teams